Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

Genetics: Expression signature identifies high-risk patients A gene expression signature identifies breast cancer patients who do poorly after endocrine therapy and might benefit from extra treatment. A team led by John Bartlett and Paul Boutros from the Ontario Institute for Cancer Research in Toro...

Full description

Bibliographic Details
Main Authors: Jane Bayani, Cindy Q. Yao, Mary Anne Quintayo, Fu Yan, Syed Haider, Alister D’Costa, Cassandra L. Brookes, Cornelis J. H. van de Velde, Annette Hasenburg, Dirk G. Kieback, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Daniel Rea, Paul C. Boutros, John M. S. Bartlett
Format: Article
Language:English
Published: Nature Publishing Group 2017-02-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-016-0003-5

Internet

https://doi.org/10.1038/s41523-016-0003-5

Similar Items